TSE:LABS MediPharm Labs (LABS) Stock Price, News & Analysis → Did Intel Just Dethrone Nvidia? (From Chaikin Analytics) (Ad) Free LABS Stock Alerts C$0.08 +0.01 (+13.33%) (As of 05/14/2024 ET) Add Compare Share Share Today's RangeC$0.08▼C$0.0950-Day RangeC$0.07▼C$0.1052-Week RangeC$0.06▼C$0.10Volume338,426 shsAverage Volume219,479 shsMarket CapitalizationC$34.34 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get MediPharm Labs alerts: Email Address Ad Stansberry ResearchHUGE BUY ALERT: Move Fast, Musk...I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line. Since 2018, my investment recommendations have averaged 115% per year. But one investment I've just discovered could blow them all away.You won't believe what I saw in Phoenix. About MediPharm Labs Stock (TSE:LABS)MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.Read More LABS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LABS Stock News HeadlinesMay 8, 2024 | finance.yahoo.comMediPharm Labs Sets Date to Report First Quarter 2024 Financial ResultsMay 7, 2024 | theglobeandmail.comClosing Bell: Medipharm Labs Corp up on Monday (LABS)March 28, 2024 | finance.yahoo.comMediPharm Labs Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 27, 2024 | finanznachrichten.deMediPharm Labs Corp.: MediPharm Labs Reports Fourth Quarter and Full Year ResultsMarch 25, 2024 | finanznachrichten.deMediPharm Labs Corp.: MediPharm Labs Provides Update on German Cannabis LegalizationMarch 22, 2024 | finance.yahoo.comMediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial ResultsFebruary 26, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - LABS.WT.BFebruary 24, 2024 | msn.comMediPharm Labs (MEDIF) Price Target Increased by 5.07% to 0.08February 19, 2024 | theglobeandmail.comMediPharm Labs: Top 10 Undervalued Drug Manufacturers Industry Stocks (LABS)February 7, 2024 | ca.finance.yahoo.comStocks in play: MediPharm Labs Corp.December 25, 2023 | finance.yahoo.comLife Science REIT PLC (JL6.SG)December 22, 2023 | msn.comKey Leadership Changes In Cannabis You Should Know About As We Head Into 2024December 22, 2023 | markets.businessinsider.comCanadian Markets Might Open Slightly UpDecember 22, 2023 | finance.yahoo.comMediPharm Labs Provides Update on Board of Directors and Long Term Incentive ProgramDecember 20, 2023 | morningstar.comMediPharm Labs Corp LABSSeptember 27, 2023 | finance.yahoo.comMediPharm Labs Launches new GMP Products to the Australian Medical Cannabis MarketSeptember 20, 2023 | marketwatch.comMediPharm Labs Buys Out Royalty Agreement With Shelter Cannabis BrandsSeptember 20, 2023 | finance.yahoo.comMediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty AgreementAugust 31, 2023 | msn.comMedical cannabis may help manage fibromyalgia, study findsAugust 15, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp down on Tuesday (LABS)June 29, 2023 | finance.yahoo.comMediPharm Labs Announces Voting Results From the 2023 Annual Meeting of ShareholdersJune 22, 2023 | marketwatch.comNutritional, Vitamin and Food Supplement Analytical Services Market Overview By Share, And Product Demand Forecast Till 2029May 22, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp down on Friday (LABS)May 15, 2023 | msn.comMediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDAMay 15, 2023 | finance.yahoo.comMediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDASee More Headlines Receive LABS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/14/2024Next Earnings (Estimated)6/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:LABS CUSIPN/A CIKN/A Webwww.medipharmlabs.com Phone705 719 7425FaxN/AEmployees130Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-13,080,000.00 Net Margins-39.57% Pretax MarginN/A Return on Equity-24.00% Return on Assets-12.01% Debt Debt-to-Equity Ratio4.33 Current Ratio3.37 Quick Ratio3.10 Sales & Book Value Annual SalesC$33.06 million Price / Sales0.98 Cash FlowC$0.06 per share Price / Cash Flow1.30 Book ValueC$0.13 per share Price / Book0.62Miscellaneous Outstanding Shares404,050,000Free FloatN/AMarket CapC$32.32 million OptionableNot Optionable Beta0.97 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. David A. PidduckCEO & DirectorMr. Keith StrachanCo-Founder & PresidentMr. Greg HunterChief Financial OfficerMr. Patrick McCutcheonFounderMr. Saravan SubramaniamVice President of Operations & Supply ChainMr. Geoffrey MarrExecutive VP & General CounselMr. Brett MoonVice President of SalesMr. Kirk BinnsExecutive Vice President of Global AccountsMore ExecutivesKey CompetitorsMeta GrowthCVE:METAInMed PharmaceuticalsTSE:INZomedica Pharmaceuticals Corp. (ZOM.V)CVE:ZOMViridium Pacific GroupCVE:VIRCharlotte's WebTSE:CWEBView All Competitors LABS Stock Analysis - Frequently Asked Questions How have LABS shares performed in 2024? MediPharm Labs' stock was trading at C$0.07 at the beginning of the year. Since then, LABS shares have increased by 30.8% and is now trading at C$0.09. View the best growth stocks for 2024 here. When is MediPharm Labs' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, June 28th 2024. View our LABS earnings forecast. What other stocks do shareholders of MediPharm Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other MediPharm Labs investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Village Farms International (VFF), Canopy Growth (WEED), Aphria (APHA), Cresco Labs (CRLBF), HEXO (HEXO), Heat Biologics (HTBX), Absolute Software Co. (ABT.TO) (ABT) and Acasti Pharma (ACST). How do I buy shares of MediPharm Labs? Shares of LABS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:LABS) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.